TRxADE HEALTH, INC. historically focused on health services IT assets and operations aimed at digitalizing the retail pharmacy experience. Our current primary operations are conducted through our ...

Tarsus Pharmaceuticals is expanding its pipeline to target meibomian gland disease and rosacea, with promising Phase 2 ...

17, 2024 /PRNewswire/ -- Revelation Pharma, a national network of 503A and 503B compounding pharmacies dedicated to providing "industry best" patient care, today launched Revelation Wholesale.

TRxADE Health (NASDAQ: MEDS), a parent company of pharmaceutical business-to-business (“B2B”) exchange platform, and Scienture Inc., a wholly owned subsidiary of TRxADE, have announced a name change.

IPOs at three biotechs last week tempted insiders to make huge share purchases. This spilled over into buying at a couple of ...

The Indian pharmaceutical sector is expected to maintain its growth, driven by a strategy focused on increasing market share ...

The sector is expected to benefit from steady cash flows and low financial leverage, which will help maintain stable credit ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

The Nifty Pharma has gained around 37% year to date. The growth continues to be led by the US sales and well supported by ...